Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ProShares Bitcoin ETF (BITO) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

ProShares Bitcoin ETFTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

ProShares Bitcoin ETF vs Zimmer Biomet Holdings Inc — how do they compare? ProShares Bitcoin ETF trades at $8.65, while Zimmer Biomet Holdings Inc trades at $97 (market cap $18.65B). The key difference: Zimmer Biomet Holdings Inc pays a 0.98% dividend while ProShares Bitcoin ETF pays none, and Zimmer Biomet Holdings Inc is trading nearer its 52-week high, ProShares Bitcoin ETF nearer its low. Which is the better fit depends on your goals.

BITOZBH
Sector
Crypto-linkedHealth
52-Week High
$22.27$107.71
52-Week Low
$7.98$79.58
Market Cap
$18.65B
Enterprise Value
$25.72B
Dividend Yield
0.98%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ProShares Bitcoin ETF

BITO trades at $8.79, up 1.03% with a bullish technical signal from moving averages. The ETF maintains a consistent dividend distribution pattern with recent $0.01 payouts. Technical indicators show neutral oscillators but overall positive momentum, with support and resistance clustered around $9. The fund's performance reflects ongoing investor interest in Bitcoin exposure vehicles despite market volatility.

BITO faces structural challenges with higher fees impacting long-term returns compared to spot Bitcoin ETFs. Recent analyst coverage highlights tactical utility but questions buy-and-hold suitability. The fund's correlation breakdown with high-beta equities and persistent crypto market headwinds present significant risk factors for investors seeking sustained growth.

Zimmer Biomet Holdings Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About ProShares Bitcoin ETF

BITO offers exposure to Bitcoin returns primarily through Bitcoin futures contracts. It provides a regulated way for investors to trade Bitcoin performance within a traditional brokerage account without direct ownership.

Read more on BITO

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH